ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Hybridon

Hybridon (HBY)

0.00
0.00
(0.00%)
Closed September 24 4:00PM
0.00
0.00
( 0.00% )

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

HBY Latest News

Hybridon Changes Name to Idera Pharmaceuticals

Idera is Developing Targeted Immune Therapies Based on Toll-like Receptors CAMBRIDGE, Mass., Sept. 12 /PRNewswire-FirstCall/ -- Hybridon, Inc. (AMEX:HBY) announced today that it has changed its...

Hybridon, Inc. to Present at ThinkEquity Growth Conference

CAMBRIDGE, Mass., Sept. 8 /PRNewswire-FirstCall/ -- Hybridon, Inc. (AMEX:HBY) announced today that Sudhir Agrawal, D.Phil, Hybridon's Chief Executive Officer and Chief Scientific Officer, will...

Hybridon, Inc., to Participate in Innate Immunity Panel at the BIO 2005 Annual International Convention

Hybridon, Inc., to Participate in Innate Immunity Panel at the BIO 2005 Annual International Convention CAMBRIDGE, Mass., June 21 /PRNewswire-FirstCall/ -- Hybridon, Inc. (AMEX:HBY) announced...

Hybridon Announces the Appointment of Robert W. Karr, M.D. to its Board of Directors

Hybridon Announces the Appointment of Robert W. Karr, M.D. to its Board of Directors CAMBRIDGE, Mass., June 17 /PRNewswire-FirstCall/ -- Hybridon, Inc. (AMEX:HBY) today announced the election of...

Hybridon Announces Collaboration to Develop Immune Modulatory (IMO) Compounds for Asthma and Allergy

Hybridon Announces Collaboration to Develop Immune Modulatory (IMO) Compounds for Asthma and Allergy IMO Compounds are Agonists of Toll-like Receptor 9 CAMBRIDGE, Mass., June 1...

Hybridon Announces $5 Million Private Financing

Hybridon Announces $5 Million Private Financing CAMBRIDGE, Mass., May 20 /PRNewswire-FirstCall/ -- Hybridon, Inc. (AMEX:HBY) announced today that it has entered into definitive agreements with...

Hybridon Presents Preclinical Data on Interferon-Alpha Induction by Toll-Like Receptor 9 Agonists

Hybridon Presents Preclinical Data on Interferon-Alpha Induction by Toll-Like Receptor 9 Agonists Cambridge, Mass., May 16 /PRNewswire-FirstCall/ -- Hybridon Inc. (AMEX:HBY) today announced the...

Hybridon Announces Oral Presentation of Results for Phase I Trial of IMOxine(R) at ASCO 2005

Hybridon Announces Oral Presentation of Results for Phase I Trial of IMOxine(R) at ASCO 2005 -- Hybridon Plans New Chemotherapy Combination Study in Non-Small Cell Lung Cancer -- CAMBRIDGE...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FDHYFidelity High Yield Factor ETF
$ 58.00
(17.48%)
8
YINNDirexion Daily FTSE China Bull 3X Shares
$ 29.64
(16.37%)
1.63M
CHAUDirexion Daily CSI 300 China A Share Bull 2X Shares
$ 13.73
(12.45%)
113.22k
CWEBDirexion Daily Csi China Internet Index Bull 2x Shares
$ 33.00
(11.26%)
137.99k
PTNPalatin Technologies Inc New
$ 1.327
(9.67%)
12.27k
YANGDirexion Daily FTSE China Bear 3X Shares New
$ 5.90
(-17.48%)
3.32M
SGNSigning Day Sports Inc
$ 0.30
(-12.23%)
645.37k
FNDCSchwab Fundamental International Small Equity ETF
$ 33.97
(-9.73%)
27
AGOXAdaptive Alpha Opportunities ETF
$ 26.81
(-6.97%)
41
FXPProShares UltraShort FTSE China 50
$ 25.40
(-6.85%)
149
SOXLDirexion Daily Semiconductor Bull 3X Shares
$ 34.61
(2.03%)
4.52M
FXIiShares China Large Cap
$ 29.20
(5.49%)
3.71M
YANGDirexion Daily FTSE China Bear 3X Shares New
$ 5.90
(-17.48%)
3.32M
SOXSDirexion Daily Semiconductor Bear 3X Shares New
$ 21.77
(-3.24%)
2.59M
KWEBKraneShares CSI China Internet
$ 28.84
(5.91%)
1.68M

Your Recent History

Delayed Upgrade Clock